Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.

Saved in:
Bibliographic Details
Title: Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
Authors: Dos Santos ES; Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil.; Service de Génétique, Institut Curie, Paris, France.; A.C.Camargo Cancer Center, São Paulo, Brazil., Caputo SM; Service de Génétique, Institut Curie, Paris, France., Castera L; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France., Gendrot M; Service de Génétique, Institut Curie, Paris, France., Briaux A; Service de Génétique, Institut Curie, Paris, France., Breault M; Service de Génétique, Institut Curie, Paris, France., Krieger S; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France., Rogan PK; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada., Mucaki EJ; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada., Burke LJ; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia., Bièche I; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France., Houdayer C; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France., Vaur D; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France., Stoppa-Lyonnet D; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France., Brown MA; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia., Lallemand F; Service de Génétique, Institut Curie, Paris, France. francois.lallemand@curie.fr., Rouleau E; Gustave Roussy, Villejuif, France. Etienne.rouleau@gustaveroussy.fr.
Corporate Authors: ENIGMA consortium
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Apr; Vol. 168 (2), pp. 311-325. Date of Electronic Publication: 2017 Dec 13.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29236234
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dos+Santos+ES%22">Dos Santos ES</searchLink>; Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil.; Service de Génétique, Institut Curie, Paris, France.; A.C.Camargo Cancer Center, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Caputo+SM%22">Caputo SM</searchLink>; Service de Génétique, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Castera+L%22">Castera L</searchLink>; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France.<br /><searchLink fieldCode="AU" term="%22Gendrot+M%22">Gendrot M</searchLink>; Service de Génétique, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Briaux+A%22">Briaux A</searchLink>; Service de Génétique, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Breault+M%22">Breault M</searchLink>; Service de Génétique, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Krieger+S%22">Krieger S</searchLink>; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France.<br /><searchLink fieldCode="AU" term="%22Rogan+PK%22">Rogan PK</searchLink>; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada.<br /><searchLink fieldCode="AU" term="%22Mucaki+EJ%22">Mucaki EJ</searchLink>; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada.<br /><searchLink fieldCode="AU" term="%22Burke+LJ%22">Burke LJ</searchLink>; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Bièche+I%22">Bièche I</searchLink>; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France.<br /><searchLink fieldCode="AU" term="%22Houdayer+C%22">Houdayer C</searchLink>; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vaur+D%22">Vaur D</searchLink>; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France.<br /><searchLink fieldCode="AU" term="%22Stoppa-Lyonnet+D%22">Stoppa-Lyonnet D</searchLink>; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France.<br /><searchLink fieldCode="AU" term="%22Brown+MA%22">Brown MA</searchLink>; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Lallemand+F%22">Lallemand F</searchLink>; Service de Génétique, Institut Curie, Paris, France. francois.lallemand@curie.fr.<br /><searchLink fieldCode="AU" term="%22Rouleau+E%22">Rouleau E</searchLink>; Gustave Roussy, Villejuif, France. Etienne.rouleau@gustaveroussy.fr.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ENIGMA+consortium%22">ENIGMA consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2018 Apr; Vol. 168 (2), pp. 311-325. <i>Date of Electronic Publication: </i>2017 Dec 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29236234
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-017-4602-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 311
    Titles:
      – TitleFull: Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dos Santos ES
      – PersonEntity:
          Name:
            NameFull: Caputo SM
      – PersonEntity:
          Name:
            NameFull: Castera L
      – PersonEntity:
          Name:
            NameFull: Gendrot M
      – PersonEntity:
          Name:
            NameFull: Briaux A
      – PersonEntity:
          Name:
            NameFull: Breault M
      – PersonEntity:
          Name:
            NameFull: Krieger S
      – PersonEntity:
          Name:
            NameFull: Rogan PK
      – PersonEntity:
          Name:
            NameFull: Mucaki EJ
      – PersonEntity:
          Name:
            NameFull: Burke LJ
      – PersonEntity:
          Name:
            NameFull: Bièche I
      – PersonEntity:
          Name:
            NameFull: Houdayer C
      – PersonEntity:
          Name:
            NameFull: Vaur D
      – PersonEntity:
          Name:
            NameFull: Stoppa-Lyonnet D
      – PersonEntity:
          Name:
            NameFull: Brown MA
      – PersonEntity:
          Name:
            NameFull: Lallemand F
      – PersonEntity:
          Name:
            NameFull: Rouleau E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2018 Apr
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 168
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1